(Axios) – There’s a notable gap in new federal rules requiring insurers to streamline decisions on whether they’ll cover treatments ordered by doctors: They don’t apply to drugs. Why it matters: Drugs account for a significant share of prior authorization requests, and patients and doctors argue that the new rules, as is, won’t increase access to needed treatments. (Read More)